BioVie completes enrollment in long COVID treatment trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. ACN
3. NVDA
4. APGE
5. USO
6. GOOGL
7. MU
8. HOOD
9. DFTX
10. RGNX

Go back to BioVie completes enrollment in long COVID treatment trial
(NASDAQ: BIVI) Delayed: 1.92 +0.16 (9.09%)
Previous Close $1.76    52 Week High $0.40 
Open $1.79    52 Week Low $0.17 
Day High $2.12    P/E N/A 
Day Low $1.86    EPS $0.00 
Volume 588,574